FDA Device Intelligence
Home › CAROLINA LIQUID CHEMISTRIES CORPORATION › CAROLINA LIQUID CHEMISTRIES CORP.® CYST CYSTATIN CC691

CAROLINA LIQUID CHEMISTRIES CORP.® CYST CYSTATIN CC691

CAROLINA LIQUID CHEMISTRIES CORPORATION · Model CC691 · UDI-DI 00817302020069

NDYJITJJX Prescription
10
510(k) clearances
21
Adverse events
4
Recalls
24
Facilities

Description

CYST (Cystatin-C) 2 x 100 tests

Recalls

DateFirmReason
2024-06-07Randox Laboratories Ltd.Cystatin C Reagent marketed without a 510 (k)
2024-02-14Randox Laboratories Ltd.Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods
2020-09-02Gentian ASThe firm has identified lots of calibrators that have shown to measure incorrect high values over time compared to the assigned values when released for distribution. This could re
2018-03-05Tosoh Bioscience IncAsfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.